These Analysts Cut Their Forecasts On CarMax After Downbeat Q2 Results

CarMax (KMX) posted weaker-than-expected second-quarter results, with earnings per share of $0.64 significantly missing the $1.09 consensus and sales of $6.594 billion falling short of the $7.024 billion estimate and down 6% year-over-year. This substantial underperformance prompted multiple analyst downgrades and significant price target reductions, signaling market concerns despite management's affirmation of its long-term strategy, with KMX shares declining 0.4%.

Analysis

CarMax Inc. reported a significantly weaker-than-expected second quarter, with earnings per share of $0.64 falling 41% short of the $1.09 consensus estimate. Revenue of $6.594 billion not only missed the Street's $7.024 billion forecast but also marked a 6% year-over-year decline, indicating broad operational weakness. This underperformance extends to its vehicle sourcing, with total acquisitions declining 2.4% and, more critically, vehicles bought from consumers falling 2.7%, suggesting challenges in both consumer demand and inventory pipeline. The market's response was a swift and severe reassessment by analysts, evidenced by a wave of substantial price target reductions. Notably, even analysts maintaining 'Buy' or 'Outperform' ratings, such as those at Needham and Baird, slashed their targets by over 30% to the $60 range. The sentiment was further soured by a downgrade from Evercore ISI Group to 'In-Line' with a new target of $52, signaling a fundamental shift in expectations that overshadows management's public confidence in its long-term strategy.

Key Decisions for Investors

• Given the magnitude of the earnings miss and the sharp, widespread cuts to analyst price targets, investors should anticipate continued downward pressure on KMX and consider reducing exposure to mitigate near-term volatility.
• Monitor future reports for any stabilization in retail unit sales and consumer vehicle acquisition rates, as a recovery in these core metrics is critical for validating the remaining bullish theses from analysts like Needham and RBC.
• The downgrade from Evercore ISI and the new cluster of price targets in the $47-$60 range signal a fundamental re-rating of the stock; investors should re-evaluate their investment case if it was predicated on prior, higher growth and profitability assumptions.